|
Navigation
Recherche
|
The Uncertain Path Forward for Psychedelic Medicine
jeudi 15 août 2024, 23:20 , par Wired: Tech.
After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.
https://www.wired.com/story/where-does-psychedelic-assisted-therapy-go-next-mdma-fda-lykos/
Voir aussi
|
56 sources (32 en français)
Date Actuelle
ven. 22 nov. - 01:39 CET
|
Lire la suite sur Wired: Tech.
